The Research and Development team at Universal Cells focuses on advancing stem cell therapies to combat immune rejection and enable off-the-shelf therapeutic products. They utilize proprietary genome editing techniques to engineer Universal Donor Stem Cells that are HLA-incompatible, ensuring compatibility with all patients. The team is comprised of various levels of researchers and scientists, including associates specializing in gene editing, vector production, cell biology, pharmacology, and in vivo biology, all working collaboratively to innovate and commercialize cutting-edge stem cell solutions.
View all